Pelican Biotech And Chemical Labs Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 3.68 M
- Company Age 16 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.03 Cr
- Satisfied Charges ₹ 1.60 M
- Revenue Growth -36.56%
- Profit Growth 32.63%
- Ebitda 531.71%
- Net Worth -5.13%
- Total Assets -5.17%
About Pelican Biotech And Chemical Labs
Company Details
-
Location
Alappuzha, Kerala, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U73100KL2008PTC022486
-
Company No.
022486
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
26 May 2008
-
Date of AGM
30 Dec 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Pelican Biotech And Chemical Labs?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chuzattil Manoj
|
Managing Director | 26-May-2008 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Priya Rao
|
Director | 26-May-2008 | Current |
Financial Performance of Pelican Biotech And Chemical Labs.
Pelican Biotech And Chemical Labs Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 36.56% decrease. The company also saw a substantial improvement in profitability, with a 32.63% increase in profit. The company's net worth dipped by a decrease of 5.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pelican Biotech And Chemical Labs?
Unlock access to Pelican Biotech And Chemical Labs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Pelican Thermogenics Private LimitedPriya Rao and Chuzattil Manoj are mutual person
-
Pelican Kenterra Private LimitedPriya Rao and Chuzattil Manoj are mutual person
Charges (Loans)
₹10.29 M
₹1.60 M
Charges Breakdown by Lending Institutions
- Department Of Biotechnology : 0.80 Cr
- Others : 0.23 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Sep 2020 | Others | ₹0.42 M | Open |
| 24 Sep 2020 | Others | ₹0.17 M | Open |
| 29 Sep 2010 | Department Of Biotechnology | ₹8.00 M | Open |
| 29 Mar 2010 | Others | ₹1.70 M | Open |
| 29 Mar 2010 | The Federal Bank Limited | ₹0.60 M | Satisfied |
How Many Employees Work at Pelican Biotech And Chemical Labs?
Pelican Biotech And Chemical Labs has a workforce of 4 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pelican Biotech And Chemical Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pelican Biotech And Chemical Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
